List

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until April, 2020.

  1. Malarial Retinopathy Screening System for Improved Diagnosis of Cerebral Malaria

    SBC: Visionquest Biomedical LLC            Topic: NIAID

    DESCRIPTION provided by applicant Cerebral malaria CM is a life threatening neurological complication associated with malarial infection Malaria affects about million people worldwide and claims lives annually of whom are African children under years of age CM is mistakenly over diagnosed about of the time in which the cases of concurrent non CM diseases with simil ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  2. A Phase a clinical trial of ALK in geographic atrophy

    SBC: ALKEUS PHARMACEUTICALS, INC.            Topic: NEI

    DESCRIPTION provided by applicant The long term goal of this work is to develop an oral drug for the prevention of age related macular degeneration AMD AMD is the leading cause of blindness in the United States with million Americans diagnosed or at risk of irreversibly losing vision and over million people who already have debilitating vision loss Currently there is no FDA approved ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  3. A high volume parallel acoustic flow cytometer for the detection of rare cells or particles in a large sample volume with a low background concentration i e very dilute samples

    SBC: ETA DIAGNOSTICS, INC            Topic: 400

    DESCRIPTION provided by applicant Many biomedical applications require the detection of rare cells or particles in large sample volumes These applications can be divided into those that require the detection of highly dilute cells in a large sample volume and those that require the detection of rare cells in a high background concentration of similar cells within a large volume Though flow cy ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  4. Multimodal Image Analysis Software for Epilepsy

    SBC: Electrical Geodesics, Inc.            Topic: 108

    DESCRIPTION provided by applicant Epilepsy is a debilitating brain disorder and surgery is the key treatment modality for those patients whose seizures cannot be controlled medically Epilepsy surgery is complex requiring multimodal imaging data for planning and execution and image analysis software is essential for this process The overall goal of this application is to develop a robust com ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  5. A Cytomegalovirus based therapeutic vaccine against oncogenic human papillomaviruses

    SBC: TOMEGAVAX, INC.            Topic: 102

    Abstract High risk human papillomaviruses HPV cause cervical cancer the second most common neoplasm among women globally and a large proportion of oropharyngeal cancers Although prophylactic vaccines to HPV are effective they have no therapeutic effect and thus do not benefit the millions of individuals already infected Thus there is both a medical need and a commercial opportunity for a HP ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  6. Mobility Life Monitoring Mobility in Daily Lives of People with Neurological Disease

    SBC: APDM, INC.            Topic: NIA

    Project Summary Falls are the leading cause of injuries hospital visits nursing home admissions and reduced quality of life for people with neurological disorders Although there is consensus that impaired mobility is the basis for most falls it is very di cult to evaluate these complex abilities outside a laboratory setting Brief clinical examinations do not accurately re ect daily function ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  7. Development and Commercialization of an Innovative Rapid HIV Incidence Assay

    SBC: SEDIA BIOSCIENCES CORPORATION            Topic: NIAID

    DESCRIPTION provided by applicant The objective of this Phase II project is to develop a commercially viable point of care Rapid HIV Incidence Assay the Asant Rapid HIV Recency Assay and establish its suitability for determination of recency of HIV infection in whole blood plasma serum specimens for epidemiological research and surveillance purposes from liquid blood serum or plasm ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  8. Glycosaminoglycans to Treat and Prevent Radiation Induced Oral Mucositis

    SBC: GLYCOMIRA, LLC            Topic: NIDCR

    ABSTRACT Oral mucositis is a devastatingly painful inflammatory disease that frequently develops during cancer therapy and affects half a million people in the US The accompanying pain is so severe that patients often require narcotic pain medicines The clinical manifestations are ulcers in the mouth and gastrointestinal tract which are exacerbated by opportunistic infections Many patients al ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  9. Quantitative Biomarkers of T D Peripheral Neuropathy using Functional Imaging

    SBC: Visionquest Biomedical LLC            Topic: 200

    Summary The objective of this project is to validate the i RxTherm VisionQuest s patented functional thermal imaging system that produces biomarkers for early detection of diabetic peripheral neuropathy DPN This device is based on the principle that changes in microvascular function are correlated to quantifiable changes in nerve function as expressed in measureable microvascular changes Dia ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health
  10. Novel Nanofiltration Membranes for Isolation of Pharmaceutical Compounds II

    SBC: COMPACT MEMBRANE SYSTEMS, INC.            Topic: 300

    DESCRIPTION provided by applicant In the manufacture of pharmaceutical compounds organic syntheses are often carried out in organic solvents These solvents must then be separated from high value intermediates and active pharmaceutical ingredients APIs in order to produce the final product medications Many intermediate compounds and APIs are thermally labile and thermal separation processes ...

    SBIR Phase II 2016 Department of Health and Human ServicesNational Institutes of Health

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government